Atlas Trials

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

Clinical trial NCT02956512 · COMPLETED

Trial details

NCT number
NCT02956512
Sponsor
Apsen Farmaceutica S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2019-03-18
Primary completion
2019-07-12
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.